Delivery Order SPE2DB22D3501-SPE2DB25FWE67
Award Date
6/26/25
Potential Completion Date
6/27/25
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Verzenio 150 mg tablets, a medication used to treat certain types of breast cancer. The contract has a ceiling value of $16,229.44 and a performance period extending through May 13, 2025. This order is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $93,904.60, is for the provision of Verzenio 100 mg tablets, a medication used to treat certain types of breast cancer. The contract is a firm fixed-price arrangement with an ultimate completion date of October 23, 2024. This contract award is not designated as a set-aside. AmerisourceBergen is the prime contractor, and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,101.24. The contract is for the delivery of 150 mg Verzenio tablets, a prescription medication used to treat breast cancer. The contract has a firm fixed price and is not set aside for any specific business type. The period of performance runs through November 13, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $23,859.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Verzenio 100 mg tablets, a prescription medication used to treat breast cancer. It is a firm fixed-price contract with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $7,245.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Verzenio 150 mg tablets, a medication used for the treatment of certain types of breast cancer. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 19, 2024. It is not designated as a set-aside contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VERZENIO 150 MG TABLET, a pharmaceutical product. The contract has a firm fixed price of $23,815.66 and a completion date of June 11, 2025. This contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $17,909.02 contract is for the supply of the medication Verzenio 50 mg tablets, which is used to treat certain types of breast cancer. The award is not set aside for any specific business category. The contract has an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corporation...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,245.28 firm-fixed-price contract is for the delivery of Verzenio 50 mg tablets, a medication used to treat a specific medical condition. The contract has a completion date of May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which enables...
This is a $35,440.74 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of VERZENIO 150 MG TABLET. The contract has an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including medications across multiple therapeutic domains. This...
This is a $9,965.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Verzenio 50 mg tablets, a medication used to treat a certain type of breast cancer. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...